Stock screener

QURE

SetupConviction 71LongHealthcareScan · Thu, Jun 25, 2026
High tight flagLong legged dojimomentum
QURE$49.08+0.47%
ResistanceSupportVol 14Insider sell
63 bars
2
10
2
Vol MA14 3.46M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest -37.50%· 5 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25

Trade plan

LongReward : Risk0.88
Entry
Entry
50.08
Risk
Stop
42.97
-14.2% to stop
Reward
Target 1
56.32
+12.5% to target
Stretch
Target 2
62.56
+24.9% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

uniQure N.V.PHARMACEUTICAL PREPARATIONSwww.uniqure.com
Price49.08
Change+0.47%
Gap+0.78%
Rel volume1.58×
Avg volume3.05M
Avg $ vol125.03M
SMA 2033.40
SMA 5026.62
SMA 20028.13
Price vs 50+84.38%
Price vs 200+74.45%
MA stackmixed
50/200 cross
Supertrendup · 37.92
RSI (14)77
MACD hist2.08
MACD crossbull · 5d
Stoch %K / %D95 / 95
ADX (14)45
+DI / −DI45 / 9
RSI divergenceBearish
MACD divergenceBearish
ATR %+7.05%
ADR %7.31%
52w high70.59
52w low9.03
From 52w high-30.47%
Above 52w low+443.52%
New 52w highNo
SqueezeOff
Bollinger width112.76%
%B0.92
Donchian pos95.29%
Donchian high50.30
Donchian low24.39
AVWAP (52w high)24.56
vs AVWAP high+99.86%
AVWAP (52w low)23.76
vs AVWAP low+106.60%
OBV trendUp
Chaikin MF (20)0.09
Today vs 20d1.58×
Avg vol (14d)3.46M
Avg vol (20d)3.05M
Avg $ vol (20d)125.03M
Market cap3.1B
RS 3m (vs SPY)+209.55%
RS 6m (vs SPY)+95.89%
RS line new highYes
Trend template5/8
Technical rank96.8
1 week+1.91%
1 month+95.15%
3 months+200.00%
6 months+96.48%
1 year+245.15%
YTD+109.83%
P/E-15.56
P/B20.73
P/S
P/FCF-17.35
EPS-3.46
Div yield
ROE-133.23%
ROA-25.55%
Debt/Eq0.41
Current10.40
EV/EBITDA-17.68
Gross margin
Net margin
Rev growth
EPS growth16.94%
Price target63.00
Target upside28.36%
Analyst ratingBuy
Institutional98.79%
Ent. value3.02B
Revenue3.56M
Net income-53.53M
Gross profit
Free cash flow-178.4M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out63.07M
Employees221
ListedWed, Feb 5, 2014
Free float55.88M
Float %89.4%
Short interest11.1M
Days to cover9.0d
Short volume39.3%
Squeeze score73 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.90 · 3 est
Last EPS vs est−$0.85 vs −$0.88
Last surprise+3.4% beat
Setup gradeB
Conviction71 / 100
Pattern quality79%
Tech rank96.8 / 100
Group rank50 / 100
Status laneSetting up
Setup directionLong
Pattern familyMomentum
Resistance50.08
Support43.84
Days since event
Candle confirmLong legged doji
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QURE

All disclosures →
No recent disclosed trades by Congress in QURE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QURE · 3 buys · 7 sells

InsiderSideShares
Kapusta Matthew C
CEO, Managing Director · Ordinary Shares · 2026-06-18
Exercise4.66K
Kapusta Matthew C
CEO, Managing Director · Stock Option (Right to Buy) · 2026-06-18
Exercise4.66K
Kapusta Matthew C
CEO, Managing Director · Ordinary Shares · 2026-06-18
Sell37.02K
Kapusta Matthew C
CEO, Managing Director · Ordinary Shares · 2026-06-18
Sell4.66K
Balachandran Madhavan
Director · Ordinary Shares · 2026-06-17
Sell4.7K
Balachandran Madhavan
Director · Ordinary Shares · 2026-06-17
Sell1.69K
Balachandran Madhavan
Director · Stock Option (Right to Buy) · 2026-06-17
Exercise5.29K
Kapusta Matthew C
CEO, Managing Director · Stock Option (Right to Buy) · 2026-06-17
Exercise62.58K
Balachandran Madhavan
Director · Ordinary Shares · 2026-06-17
Exercise5.29K
Balachandran Madhavan
Director · Ordinary Shares · 2026-06-17
Exercise6.39K

SEC filings

EDGAR filings in QURE · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.